Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Real-Life Experience on Dolutegravir and Lamivudine as Initial or Switch Therapy in a Silver Population Living with HIV
Maria Mazzitelli, Lolita Sasset, Samuele Gardin, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1740-1740
Open Access | Times Cited: 11

Showing 11 citing articles:

Real-World Effectiveness and Tolerability of Dolutegravir and Lamivudine 2-Drug Regimen in People Living with HIV: Systematic Literature Review and Meta-Analysis
Jeremy Fraysse, Julie Priest, Matthew Turner, et al.
Infectious Diseases and Therapy (2025)
Open Access
Changing Prevalence of AIDS and Non-AIDS-Defining Cancers in an Incident Cohort of People Living with HIV over 28 Years
Anna Maria Cattelan, Maria Mazzitelli, Nicolò Presa, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 70-70
Open Access | Times Cited: 7
Challenges of HIV Management in an Aging Population
Alvin G. Thomas, Jennifer Hoy
Current HIV/AIDS Reports (2024) Vol. 22, Iss. 1
Closed Access | Times Cited: 2
Spatiotemporal Analysis of HIV/AIDS Incidence in China From 2009 to 2019 and Its Association With Socioeconomic Factors: Geospatial Study
Ziyi Xie, Bowen Chen, Zhizhuang Duan
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e56229-e56229
Open Access | Times Cited: 1
Individualizing Antiretroviral Therapy in the Older Patient
Jennifer Hoy
Drugs & Aging (2024)
Closed Access | Times Cited: 1
Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care
Gerald Pierone, Laurence Brunet, Jennifer S Fusco, et al.
HIV/AIDS - Research and Palliative Care (2024) Vol. Volume 16, pp. 133-140
Open Access
Spatiotemporal Analysis of HIV/AIDS Incidence in China From 2009 to 2019 and Its Association With Socioeconomic Factors: Geospatial Study (Preprint)
Ziyi Xie, Bowen Chen, Zhizhuang Duan
(2024)
Open Access
Real‐world effectiveness and safety of switching to dolutegravir/lamivudine among people living with HIV‐1 aged over 50 years who are virologically suppressed
Carmela Piñeiro, Sara Policarpo, Carlos Caldas, et al.
HIV Medicine (2024)
Open Access
Efficacy and Tollerability of INI-Based 2-Drug Regimen In Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis
Antonio Russo, Salvatore Martini, Mariantonietta Pisaturo, et al.
Infection and Chemotherapy (2024) Vol. 56, Iss. 3, pp. 395-395
Open Access
Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States
Gerald Pierone, Jennifer S Fusco, Laurence Brunet, et al.
AIDS Research and Therapy (2024) Vol. 21, Iss. 1
Open Access
Impact of oral early antiviral therapies for mild–moderate COVID-19 in the outpatient’s setting during Omicron era: a pharmacoeconomic analysis
Vincenzo Scaglione, Samuele Gardin, Lolita Sasset, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access
Page 1

Scroll to top